// App-Quantinova.ai

P329 : Which should come first? Surgery or biologic therapy for ileocaecal Crohn’s disease in biologic naïve patients

Researchers

Presenter

  • Witjes, C

Principal Investigators

  • Patel, A

  • Zocche, D

  • van 't Hullenaar- , C

  • Cripps, S

  • Travis, S

  • George, B

Medical Centers

  • Oxford University Hospital- NHS Foundation Trust- Oxford, Department of Colorectal surgery, Oxford, United Kingdom

  • Ijsselland Hospital, Department of General Surgery and Colorectal Surgery-, Capelle aan den IJssel, The Netherlands

  • University Hospitals Coventry and Warwickshire NHS Trust, Department of Gastroenterology, Coventry, United Kingdom

  • Oxford University Hospital- NHS Foundation Trust, Pharmacy Department – Gastroenterology/Hepatology, Oxford, United Kingdom

  • Oxford University Hospital, Translational Gastroenterology Unit, Oxford, United Kingdom

Locations

  • United Kingdom

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Crohn's disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved